
|
|||
![]() |
Curriculum vitae
Name: Professor Dr. Dr. Eleftherios Vairaktaris
Born: June 10, 1950
Place of birth: Piraeus
Affiliation: Director of the Athens University Clinic for Maxillofacial Surgery
“Attikon” University Hospital
Rimini 1, 12462 Haidari, Greece
E-mail: lvairakt@med.uoa.gr
Tel: 0030 – 210 – 58.31.544
FAX: 0030 – 210 – 67.70.886
ACADEMIC TITLES:
1975 Degree in Dentistry (University of Thessaloniki)
1987 Degree in Medicine (University of Thessaloniki)
1984 PhD in Dentistry (University of Athens)
1992 PhD in Medicine (University of Athens)
POSTGRADUATE EDUCATION ABROAD:
Four and a half years of continuous experience in University Clinics abroad in salaried positions, as follows:
10/1/76 - 1/4/79 three years salaried assistant at the Christian Albrechts University in Kiel, Germany,
6/1/92 – 30/6/92 six months in Hanover, Germany,
1/4/94 – 7/5/95 one year in Tübingen, Germany.
POSTGRADUATE EDUCATION IN GREECE:
Three and a half months in the Emergency Care Unit and the Experimental Surgery Department, 2nd ClinicofSurgery,UniversityofAthens,“Aretaieion” Hospital, Athens.
APPOINTMENTS:
- Professor of Maxillofacial Surgery, (2009 – present). Surgical Department, School of Medicine, University of Athens, Greece.
- Director of the Athens University Clinic for Maxillofacial Surgery, “Attikon” University Hospital, Rimini 1, 12462 Haidari, Greece.
- Scientific Responsible for the Craniomaxillofacial Surgery Unit and Relevant Syndromes, 1st Paediatric Clinic (Director: Professor G. Roussos).
INTERNATIONAL COLLABORATION – DISTINCTION:
- Reviewer in 11 international scientific journals.
- Member in the Editorial Board of 3 international scientific journals (Oral Oncology, Oral & Maxillofacial Surgery, International Journal of Clinical Dentistry).
- 1st prize for best basic science research in the International Congress of Oral Oncology (Amsterdam, May 17 – 20, 2007).
- Close collaboration with pioneer clinics from Europe.
CLINICAL EXPERIENCE:
1976 – 1979 Scientific assistant at the University Clinic for Oral and Maxillofacial Surgery in Kiel, Germany
1981 Clinic for Oral and Maxillofacial Surgery at the “Laiko” Hospital
1982 - 1986 Consultant at the Clinic for Oral and Maxillofacial Surgery at the “KAT” Hospital
1986 - 1996 Lector, Assistant Professor and Associated Professor University Clinic for Oral and Maxillofacial Surgery at the “Evagelismos” Hospital (excluding a sabbatical for advanced studies)
1996 - 1998 Director of the University Clinic for Oral and Maxillofacial Surgery at the “A & P Kyriakou” Children Hospital
Since 2005 Director of the Clinic for Oral and Maxillofacial Surgery at the University Hospital “Attikon”
MAIN RESEARCH TOPICS:
- Craniofacial Surgery
- Plastic and Reconstructive Surgery
- Oral Cancer Experimental Research
- Genetic Association Studies
- Oral Cancer and Diabetes
MEMBERSHIPS:
Member of:
- the Εuropean Association for Cranio–Maxillofacial Surgery
- the British Association of Oral and Maxillofacial Surgeons (associate Member).
- the Deutsche Gesellschaft fuer Mund–, Kiefer– und Gesichtschirurgie (aussserordentliches)
- 7 Greek Scientific Companies
PUBLICATIONS
- 167 Scientific Articles:
104 of which are in Journals with Impact Factor
10 of which are Abstracts in Journals with Impact Factor
20 of which are in International Journals without Impact Factor
33 of which are in Greek Scientific Journals
- More than 175 Lectures in Scientific Congresses
- 1 Book
- 2 Book Contributions
No |
PART A. List of Publications in International Journals without Impact Factor |
1 |
Ossifying fibroma of the jaws. Review of the literature and report of 16 cases. |
2 |
Fractures of the facial skeleton in the edentulous patient. |
3 |
The superior orbital fissure syndrome. Review of the literature and report of four cases. |
4 |
Traumatic Le Fort III osteotomy. |
5 |
Aneurysmal bone cyst of the jaws. Review of the literature and report of 2 cases. |
6 |
Benign neurogenic tumors of the oral cavity. |
7 |
Orbital apex syndrome. |
8 |
Plasma cell myeloma of the jaws. |
9 |
Metastatic tumors to the jaws: A report of seven cases. |
10 |
Mycobacterial cervical lymphadenitis. A clinicopathological study of 3 cases. |
11 |
Lingual Thyroid: a new surgical approach - A case report. |
12 |
Blood supply to the oral and maxillofacial tissues following radiation therapy: a prospective ultrasonographic study. |
13 |
Light induced changes in quinolone levels in rat serum and tissues. |
14 |
Untreated 'blow-in' fracture of the orbital floor causing a mucocele: report of an unusual late complication. |
15 |
Salivary gland manifestations of sarcoidosis: report of three cases. |
16 |
Are factor V and prothrombin mutations associated with increased risk of oral cancer? |
17 |
Immediate versus delayed loading of dental implants in the maxillae of minipigs. Part II: histomorphometric analysis. |
18 |
Orbital abscess: visual loss following extraction of a tooth - Case report. |
19 |
Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. |
20 |
Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. |
21 |
Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer. |
22 |
Determination of facial symmetry in unilateral cleft lip and palate patients from three-dimensional data: technical report and assessment of measurement errors. |
23 |
Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. |
24 |
H3 Propranolol serum levels following lidocaine administration in rats with CCL4 induced liver damage. |
25 |
Nasolabial symmetry following Tennison-Randall lip repair: a three-dimensional approach in 10-year-old patients with unilateral clefts of lip, alveolus and palate. |
26 |
The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis. |
27 |
Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk for oral cancer. |
28 |
FGFR-2 and -3 play an important role in initial stages of oral oncogenesis. |
29 |
Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. |
30 |
Solitary fibrous tumor in the tongue: Case report and review of the literature. |
31 |
Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis. |
32 |
The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. |
33 |
Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. |
34 |
Patient centred outcomes comparing transmucosal implant placement with an open approach in the maxilla: a prospective, non-randomized pilot study. |
35 |
Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. |
36 |
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. |
37 |
Long-term survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. |
38 |
Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Caucasians. |
39 |
Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. |
40 |
The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. |
41 |
Craniectomy and noggin application in an infant model. |
42 |
Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis. |
43 |
The 1040 C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor (TAFI) is associated with risk for oral cancer. |
44 |
Coagulation-related factors Thrombomodulin and protein Z are not associated with risk for oral cancer. |
45 |
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. |
46 |
Conventional Radiographs: Are they still the standard in localisation of shotgun pellets? |
47 |
Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential. |
48 |
Diabetes Does Not Influence Oral Oncogenesis Through Fibroblast Growth Factor Receptors. |
49 |
Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. |
50 |
Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII. |
51 |
Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis. |
52 |
EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis. |
53 |
Evaluation of apoptosis in nasal and buccal cells of septic patients. |
54 |
Proof of Direct Radiogenic Destruction of Collagen in Vitro. |
55 |
Increased risk for oral cancer in diabetic animals is not associated with c-jun activation pathway. |
56 |
The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer. |
57 |
The Interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer. |
58 |
A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer. |
59 |
Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer. |
60 |
The platelet glycoprotein Ibα VNTR polymorphism is associated with risk for oral cancer. |
61 |
Diabetes and Oral Oncogenesis. |
62 |
Diabetes enhances cell proliferation but not Bax/Bcl-2 mediated apoptosis during oral oncogenesis. |
63 |
Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma. Long-term survival in a prospective, non-randomized study. |
64 |
Expression of MAGE - A12 in oral squamous cell carcinoma. |
65 |
Expression of melanoma associated antigens in oral squamous cell carcinoma. |
66 |
Vascular mapping of head and neck: Computed tomography versus digital subtraction angiography. |
67 |
The interleukin-10 (-1082A/G) Polymorphism is Strongly Associated with Increased Risk for Oral Squamous Cell Carcinoma. |
68 |
A DNA Polymorphism of Stromal-derived Factor-I is associated with Advanced Stages of Oral Cancer. |
69 |
A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. |
70 |
Effects of Topographical Surface Modifications of Electron Beam Melted (EBM) Ti-6A1-4V titanium on human fetal osteoblasts. |
71 |
Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats. |
72 |
Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. |
73 |
The hamster model of sequential oral oncogenesis. |
74 |
Computer-assisted orbital floor reconstruction: Use of a CAD/CAM implant with intraoperative contact-free 3D endo- and exophthalmometry. |
75 |
Enophthalmos correction in complex orbital floor reconstruction: Computer-assisted, intraoperative, non-contact, optical 3D support. |
76 |
Gene Expression Polymorphisms of Interleukins -1β, -4, -6, -8, -10, and Tumor Necrosis Factors -α, -β: |
77 |
Ιnfluence of residual alveolar bone height on implant stability in the maxilla: An experimental animal study. |
78 |
Effects of bioactive glass and beta-TCP containing three-dimensional laser sintered polyetheretherketone composites on osteoblasts in vitro. |
79 |
Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer. |
80 |
In vitro response of hFOB cells to pamidronate modified sodium silicate coated cellulose scaffolds. |
81 |
H-ras and c-fos exhibit similar expression patterns during stages of oral oncogenesis. |
82 |
Prevalence of HPV types in a cohort of Greeks with clinical indication of infection. |
83 |
Delayed Appearance of Diplopia due to Orbital Emphysema after repair of Orbital Fractures. |
84 |
Genetic association of cytokine DNA polymorphisms with head and neck cancer. (Review) |
85 |
HPV detection rate in saliva may depend on the immune system efficiency. |
86 |
Metastases following Biopsy of Oral carcinoma in Hamsters and the Role of Prebiopsy Bleomycin. |
87 |
Influence of residual alveolar bone height on osseointegration of implants in the maxilla: A pilot study. |
88 |
A common 9bp Deletion in the Ataxia-Telangiectasia-Mutated Gene is not associated with oral cancer. |
89 |
Association of Leptin -2548G/A and Leptin Receptor Q223R Polymorphisms with Increased Risk for Oral Cancer. |
90 |
Haematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: Preliminary results. |
91 |
Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. |
92 |
Prognostic impact of blood transfusion in patients undergoing primary surgery and free-flap reconstruction for oral squamous cell carcinoma. |
93 |
Orbital cellulitis, orbital subperiosteal and intraorbital abscess: Report of three cases and review of the literature. |
94 |
Diabetes enhances the expression of H-ras and suppresses the expression of EGFR leading to increased cell proliferation. |
95 |
A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma. |
96 |
Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer. |
97 |
T. TOYOSHIMA, F. KOCH, P. KAEMMERER, E. VAIRAKTARIS, B. AL-NAWAS, W. WAGNER. |
98 |
Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene. |
99 |
Osteocutaneous free flap including medial and lateral scapular crests: technical |
100 |
No reduction in complication rate by stay in the intensive care unit for patients undergoing surgery for head and neck cancer and microvascular reconstruction. |
101 |
In vitro behavior of layer-by-layer deposited molecular oligoelectrolyte films on Ti-6Al-4V surfaces. |
102 |
Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma. |
103 |
Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. |
104 |
Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. |
No |
PART B. List of Publications in International Journals without Impact Factor |
1 |
Cerebral abscess and meningitis complicated by residual mandibular ankylosis. A study of the routes that spread the infection. |
2 |
Bilateral static bone cyst associated with fracture of the mandible. |
3 |
Chondrosarcoma of the orofacial region. Review of the literature and report of two cases. |
4 |
Le Fort I Osteotomy in a Patient with Albright Syndrome. |
5 |
Adult respiratory distress syndrome in patients with maxillofacial injuries. Report of three cases. |
6 |
Aneurysmal Bone Cyst of the Mandible. A. Case Report. |
7 |
Primary Oral Kaposi's Sarcoma in a non–AIDS Patient. |
8 |
An unusual case of a huge Mixed parotid tumour. |
9 |
Leiomyosarcoma of the Mandible. |
10 |
Eagle's syndrome masked by TMJ pathosis: Report of 2 cases. |
11 |
Non ossifying fibroma of the mandible. A clinical and histologic study of one case. |
12 |
Peripheral ameloblastoma. A clinical and histologic study of one case. |
13 |
Tödliche Lungenkomplikation als Folge eines odontogen Logenabszesses. |
14 |
Laryngeal insufficiency as a post–traumatic complication of facial skull injury. |
15 |
Alkoholkonsum und Verkehrsunfälle – eine statistische Erhebung in Südwestgriechenland |
16 |
Influence of plateleled rich plasma (PRP) on bone regeneration. |
17 |
State of the art of fusion of computed tomography data and optical 3D images. |
18 |
Abundance and localization of skeletal muscle–related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis. |
19 |
Three-dimensional analysis of changes of the malar-midfacial region after LeFort I osteotomy and maxillary advancement. |
20 |
Three-dimensional analysis of facial symmetry in cleft lip and palate patients using optical surface data. |
PART C. ABSTRACTS
1. "The radicality of functional neck dissection: experience from 540 cases of composite operations".
C. MARTIS, E. VAIRAKTARIS, K. MARTIS.
Abstract in J Craniomaxillofac Surg 1992;20(6 Suppl 1):1–73.
2. “Secondary correction of fronto–naso–orbital injuries”.
T. SEMERGIDIS, E. VAIRAKTARIS, I. IATROU, C. MARTIS.
Abstract in J Craniomaxillofac Surg 1996;24:105.
3. “Malignant tumours of the salivary glands: surgical approach”.
T. SEMERGIDIS, E. VAIRAKTARIS, I. IATROU.
Abstract in Br J Surg 1997;84(2):80.
4. “Basal cell carcinoma of the face”.
E. VAIRAKTARIS, M. ALEXOPOULOU M., T. SEMERGIDIS.
Abstract in Br J Surg 1997;84(2):81.
5. “Surgical treatment of oronasal defects resulting from cocaine abuse”.
T. SEMERGIDIS, S. VASSILIOU, R. MEYER, E. VAIRAKTARIS.
Abstract in Int J Oral Maxillofac Surg 2001;30(A):S72.
6. "Prevalence of thrombophilic gene mutations in patients with oral cancer". C. YAPIJAKIS, E. VAIRAKTARIS, J. WILTFANG, J. RIES, A. VYLLIOTIS, FW. NEUKAM.
Abstract in Eur J Hum Genet 2004;12(S1):193.
7. "Common DNA polymorphisms in thrombophilia–related genes predispose for oral cancer".
C. YAPIJAKIS, E. VAIRAKTARIS, Z. SEREFOGLOU, A. VYLLIOTIS, E. NKENKE, P. KESSLER, FW. NEUKAM.
Abstract in Eur J Hum Genet 2006;14(S1):225.
8. "Genetic association studies reveal significant predisposition for oral cancer in Europeans".
C. YAPIJAKIS, Z. SEREFOGLOU, A. VYLLIOTIS, S. SPYRIDONIDOU, D. AVGOUSTIDIS, E. CRITSELIS, E. NKENKE, FW. NEUKAM, E. VAIRAKTARIS.
Abstract in Int J Mol Med 2006;18(S1):S86.
9. "Role of oncogenes and tumour suppressor genes in sequential stages of oral oncogenesis in an experimental animal model".
E.VAIRAKTARIS, V. PAPAKOSTA, S. SPYRIDONIDOU, A.VYLLIOTIS, P. STRANTZIAS, E. VORRI, D. AVGOUSTIDIS, A. LAZARIS, D. PERREA, N. KAVANTZAS, I. DONTA, S. DERKA, S. VASSILIOU, C. YAPIJAKIS, E. PATSOURIS.
Abstract in Oral Oncol 2007;2(S1):204.
10. "Risk for oral squamous cell carcinoma is inherited in one third of Europeans".
C. YAPIJAKIS, Z. SEREFOGLOU, A. VYLLIOTIS, S. SPYRIDONIDOU, M. KECHAGIADAKIS, D. AVGOUSTIDIS, E. CRITSELIS, A. CHATZITHEOFYLAKTOU, A. NIXON, E. VORRIS, E. NKENKE, F.W. NEUKAM, E. PATSOURIS, E.VAIRAKTARIS.
Abstract in Oral Oncol 2007;2(S1):126.
